Non-infectious Intermediate, Posterior and Panuveitis
1 clinical trials · Condition
◉ Watch Non-infectious Intermediate, Posterior and Panuveitis
| Record | Firm | Date |
|---|---|---|
| Post-marketing Surveillance Study of Adalimumab (Humira®) for Non-infectious Intermediate, Posterior, or Panuveitis Patients (NCT03339102) | AbbVie | 2018-01-25 |
Track Non-infectious Intermediate, Posterior and Panuveitis automatically
Every clearance here is in the API, with alerts when new ones post.